Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site

(Hong Kong SAR, China, 1996-2001 cases followed-up until 2003)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	Total included	Dead		Alive		Complete FU		Median FU (in months)
Site	ICD-10	Total included	No.	%	No.	%	No.	%	Median FU (in months)
C00	Lip	42	6	14.3	36	85.7	42	100.0	59.6
C01-02	Tongue	677	288	42.5	389	57.5	677	100.0	41.6
C03-06	Oral cavity	561	278	49.6	283	50.4	561	100.0	34.5
C07-08	Salivary gland	330	83	25.2	247	74.8	330	100.0	54.8
C11	Nasopharynx	6593	1902	28.8	4691	71.2	6593	100.0	48.7
C12-13	Hypopharynx	360	268	74.4	92	25.6	360	100.0	16.4
C15	Oesophagus	2832	2216	78.2	616	21.8	2832	100.0	9.7
C16	Stomach	5879	4009	68.2	1870	31.8	5879	100.0	15.6
C17	Small intestine	239	151	63.2	88	36.8	239	100.0	21.1
C18	Colon	11025	5506	49.9	5519	50.1	11025	100.0	35.2
C19-21	Rectum, anus	6192	2984	48.2	3208	51.8	6192	100.0	35.4
C22	Liver	9256	7445	80.4	1811	19.6	9256	100.0	5.6
C23-24	Gall bladder	1601	1303	81.4	298	18.6	1601	100.0	7.0
C25	Pancreas	1801	1552	86.2	249	13.8	1801	100.0	4.4
C30-31	Nose/Sinuses	288	119	41.3	169	58.7	288	100.0	41.6
C32	Larynx	1210	507	41.9	703	58.1	1210	100.0	41.6
C33-34	Lung	21131	17393	82.3	3738	17.7	21131	100.0	8.1
C37-38	Other thoracic organs	230	91	39.6	139	60.4	230	100.0	38.0
C40-41	Bone	256	77	30.1	179	69.9	256	100.0	49.7
C43	Melanoma skin	261	124	47.5	137	52.5	261	100.0	33.5
C44	Other skin	2586	519	20.1	2067	79.9	2586	100.0	50.7
C45	Mesothelioma	50	40	80.0	10	20.0	50	100.0	10.9
C47+C49	Connective tissue	970	341	35.2	629	64.8	970	100.0	42.6
C50	Breast	10112	1649	16.3	8463	83.7	10112	100.0	50.7
C53	Cervix	2624	756	28.8	1868	71.2	2624	100.0	48.7
C54	Corpus uteri	1863	372	20.0	1491	80.0	1863	100.0	48.7
C56	Ovary	1831	653	35.7	1178	64.3	1831	100.0	42.6
C60	Penis	161	60	37.3	101	62.7	161	100.0	44.6
C61	Prostate	3206	1271	39.6	1935	60.4	3206	100.0	38.1
C62	Testis	383	71	18.5	312	81.5	383	100.0	54.8
C64	Kidney	914	378	41.4	536	58.6	914	100.0	37.5
C67	Urinary bladder	3474	1438	41.4	2036	58.6	3474	100.0	40.5
C68	Other urinary organs	711	407	57.2	304	42.8	711	100.0	26.3
C69	Eye	65	12	18.5	53	81.5	65	100.0	49.7
C70-72	Brain & nervous system	1269	709	55.9	560	44.1	1269	100.0	27.4
C73	Thyroid	2235	240	10.7	1995	89.3	2235	100.0	58.9
C74-75	Adrenal gland, other endocrine	159	51	32.1	108	67.9	159	100.0	49.7
C81	Hodgkin lymphoma	257	50	19.5	207	80.5	257	100.0	48.7
C82-85+C96	Non-Hodgkin lymphoma	3318	1672	50.4	1646	49.6	3318	100.0	32.5
C90	Multiple myeloma	796	571	71.7	225	28.3	796	100.0	20.4
C91	Lymphoid leukaemia	561	242	43.1	319	56.9	561	100.0	36.5
C92-94	Myeloid leukaemia	1389	935	67.3	454	32.7	1389	100.0	15.1
C95	Leukaemia unspecified	141	109	77.3	32	22.7	141	100.0	4.5

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Hong Kong SAR, China, 1996-2001 cases followed-up until 2003)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Hong Kong SAR, China, 1996-2001 cases followed-up until 2003)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Hong Kong SAR, China, 1996-2001 cases followed-up until 2003)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Hong Kong SAR, China, 1996-2001 cases followed-up until 2003)
- Table5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease of breast cancer (Hong Kong SAR, China, 1996-2001)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)